Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.77
-1.12%
Mkt Cap $293.35M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-15.0%
Consensus $1.50 vs current $1.77
NASDAQ·Healthcare·Biotechnology
$1.77
-1.12%
Mkt Cap $293.35M
No recent rating data.
Price Target (1 analysts)
$1.50
Range $1.50 – $1.50
-15.0%
Consensus $1.50 vs current $1.77